Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

BMP4 gene therapy enhance… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

BMP4 gene therapy enhances insulin sensitivity but not adipose tissue browning in obese mice

Artikel i vetenskaplig tidskrift
Författare Jenny M Hoffmann
John Grünberg
Ann Hammarstedt
T. Kroon
Thomas U. Greiner
S. Maurer
I. Elias
Vilborg Palsdottir
F. Bosch
Jeremie Boucher
Shahram Hedjazifar
Ulf Smith
Publicerad i Molecular Metabolism
Volym 32
Sidor 15-26
ISSN 2212-8778
Publiceringsår 2020
Publicerad vid Wallenberglaboratoriet
Institutionen för neurovetenskap och fysiologi, sektionen för fysiologi
Institutionen för medicin, avdelningen för molekylär och klinisk medicin
Sidor 15-26
Språk en
Länkar dx.doi.org/10.1016/j.molmet.2019.11...
Ämnesord Obesity, Gene therapy, Insulin sensitivity, Adipose tissue, Skeletal, muscle, Liver, white, adipogenesis, metabolism, activation, Endocrinology & Metabolism
Ämneskategorier Endokrinologi och diabetes

Sammanfattning

Objective: Bone morphogenetic protein 4 (BMP4) adeno-associated viral vectors of serotype 8 (AAV8) gene therapy targeting the liver prevents the development of obesity in initially lean mice by browning the large subcutaneous white adipose tissue (WAT) and enhancing energy expenditure. Here, we examine whether this approach could also reduce established obesity. Methods: Dietary-induced obese C57BL6/N mice received AAV8 BMP4 gene therapy at 17-18 weeks of age. They were kept on a high-fat diet and phenotypically characterized for an additional 10-12 weeks. Following termination, the mice underwent additional characterization in vitro. Results: Surprisingly, we observed no effect on body weight, browning of WAT, or energy expenditure in these obese mice, but whole-body insulin sensitivity and glucose tolerance were robustly improved. Insulin signaling and insulin-stimulated glucose uptake were increased in both adipose cells and skeletal muscle. BMP4 also decreased hepatic glucose production and reduced gluconeogenic enzymes in the liver, but not in the kidney, in addition to enhancing insulin action in the liver. Conclusions: Our findings show that BMP4 prevents, but does not reverse, established obesity in adult mice, while it improves insulin sensitivity independent of weight reduction. The BMP antagonist Noggin was increased in WAT in obesity, which may account for the lack of browning. (C) 2019 The Author(s). Published by Elsevier GmbH.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?